Multi-event September 2025 FDA Recall Brimonidine Tartrate/timolol Maleate Ophthalmic Solution by Apotex Corp.

This Multi-event Class II drug recall was voluntarily initiated by Apotex Corp. on September 5, 2025 for the product Brimonidine Tartrate/timolol Maleate Ophthalmic Solution. The FDA reported the reason for recall as lack of assurance of sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns. The product was distributed Nationwide and the recall is currently ongoing.

Reported Recall Events

Recall Number: D-0677-2025

Reason for Recall
Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns
Initiated
09-05-2025
Reported
10-08-2025
Quantity
493,468 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide in the US
Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Richmond Hill, Ontario, Canada, L4C 5H2, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-1003-1.

Batch or Lot Expiration Information

Batch# VA0444, exp. date 01/2026
Batch# VA4608, exp. date 01/2026
Batch# TZ7016, exp. date 12/2025 UPC on Bottles: (01)0(03)60505100316 UPC on Cartons: 360505100316

Recall Number: D-0676-2025

Reason for Recall
Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns
Initiated
09-05-2025
Reported
10-08-2025
Quantity
151,034 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide in the US
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, a) 5 mL and b) 10 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Richmond Hill, Ontario, Canada, L4C 5H2, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1 (5 mL), NDC 60505-0589-2 (10 mL).

Batch or Lot Expiration Information

Lot# a)
Lot# VE0614 exp. date 12/2025 UPC:(01)00360505058914 (5 mL) b)
Lot# VE0616 exp. date 12/2025 UPC:(01)0(03)60505058921 (10 mL)